TREM2, His, Cynomolgus
TREM2, His, Cynomolgus

Immobilized TREM2, His, Cynomolgus, His Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-TREM2 Antibody, hFc Tag with the EC50 of 49.4 ng/ml determined by ELISA.

TREM2, His, Cynomolgus

TREM2, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

TREM2, His, Cynomolgus

TREM-2 (Triggering Receptor Expressed on Myeloid cells-2) is a 35 kDa type I transmembrane member of the TREM family and Ig superfamily. Mature human TREM-2 consists of a 156 amino acid (aa) extracellular domain (ECD) with one V-type Ig-like domain, a 21 aa transmembrane (TM) domain, and a 35 aa cytoplasmic tail. TREM-2 forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia.
Z04936
¥55,963.00

Ask us a question
Product Introduction
Species Cynomolgus
Protein Construction
TREM2 (His19-Ser174)
Accession # A0A2K5UY39-1		 His
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Immobilized TREM2, His, Cynomolgus at 5μg/ml (100μl/Well) on the plate can bind Anti­TREM2 Antibody, hFc Tag. Test result was comparable to standard batch
Expression System HEK293
Theoretical Molecular Weight 18.5 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 33-42 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • TREM2, His, Cynomolgus
    • TREM2, His, Cynomolgus

    Immobilized TREM2, His, Cynomolgus, His Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-TREM2 Antibody, hFc Tag with the EC50 of 49.4 ng/ml determined by ELISA.

  • TREM2, His, Cynomolgus
    • TREM2, His, Cynomolgus

    TREM2, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background TREM-2 (Triggering Receptor Expressed on Myeloid cells-2) is a 35 kDa type I transmembrane member of the TREM family and Ig superfamily. Mature human TREM-2 consists of a 156 amino acid (aa) extracellular domain (ECD) with one V-type Ig-like domain, a 21 aa transmembrane (TM) domain, and a 35 aa cytoplasmic tail. TREM-2 forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia.
Synonyms PLOSL2; TREM2; TREM-2; Trem2a; Trem2b; Trem2c

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.